Iq Eq Fund Management (Ireland) LTD Cara Therapeutics, Inc. Transaction History

Iq Eq Fund Management (Ireland) LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 18, 2023	BUY	$1.67 - $3.33 $1.28 Million - $2.55 Million	764,315 Added 904.19%	848,845 $1.43 Million
Q1 2023 May 10, 2023	BUY	$4.89 - $12.27 $40,122 - $100,675	8,205 Added 10.75%	84,530 $415,000
Q4 2022 Feb 08, 2023	BUY	$8.88 - $12.77 $33,708 - $48,474	3,796 Added 5.23%	76,325 $819,000
Q3 2022 Oct 26, 2022	SELL	$8.24 - $12.56 $497,284 - $757,996	-60,350 Reduced 45.42%	72,529 $679,000
Q2 2022 Aug 03, 2022	BUY	$7.45 - $13.84 $47,471 - $88,188	6,372 Added 5.04%	132,879 $1.21 Million
Q1 2022 Apr 28, 2022	SELL	$9.94 - $12.65 $481,503 - $612,778	-48,441 Reduced 27.69%	126,507 $1.54 Million
Q4 2021 Feb 02, 2022	BUY	$11.99 - $18.14 $219,692 - $332,379	18,323 Added 11.7%	174,948 $2.13 Million
Q3 2021 Oct 27, 2021	BUY	$11.55 - $16.06 $955,450 - $1.33 Million	82,723 Added 111.94%	156,625 $2.42 Million
Q2 2021 Jul 19, 2021	BUY	$12.38 - $29.19 $229,091 - $540,160	18,505 Added 33.4%	73,902 $1.06 Million
Q1 2021 May 11, 2021	BUY	$15.07 - $21.71 $575,869 - $829,604	38,213 Added 222.38%	55,397 $1.2 Million
Q4 2020 Jan 29, 2021	BUY	$12.72 - $16.16 $218,580 - $277,693	17,184 New	17,184 $260,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14.5M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Iq Eq Fund Management (Ireland) LTD, based on Form 13F filings with the SEC.

Stay updated on Iq Eq Fund Management (Ireland) LTD with notifications on news.